Daily Bulletin

Men's Weekly

.

We have a vaccine for hepatitis B but here's why we still need a cure

  • Written by Peter Revill, Senior Medical Scientist at VIDRL, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity
We have a vaccine for hepatitis B but here's why we still need a cureAround 5% of adults and 90% of babies who contract hepatitis B go on to have life-long infection that can only be managed with regular medication.Ronald Rampsch/Shutterstock

Hepatitis B is blood-borne virus that packs a punch. Worldwide, more than 1.3 billion people have been infected with hepatitis B, and 257 million people have developed a...

Read more: We have a vaccine for hepatitis B but here's why we still need a cure

Business News

How HZad Education Supports International Students Preparing for CELPIP in Australia

As Australia officially accepts CELPIP (Canadian English Language Proficiency Index Program) for visa applications, international students face new opportunities alongside unprecedented preparation ch...

Daily Bulletin - avatar Daily Bulletin

Online Site Inductions for Busy HR Teams

Induct For Work, the Australian platform for frontline onboarding and compliance, has launched Compliance Hub, a fully integrated, real-time workflow designed specifically for the fast-paced, highly m...

Daily Bulletin - avatar Daily Bulletin

Reporting Tools in Cybersecurity and Penetration Testing

Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals